LP157327-0
Dolutegravir
Active
Description
Dolutegravir is an experimental new drug under investigation for the treatment of HIV infection. Dolutegravir is an integrase inhibitor. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Wikipedia
Basic Part Properties
- Part Name
- Dolutegravir
- Part Display Name
- Dolutegravir
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2012-09-14
- Construct for LOINC Short Name
- Dolutegravir
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 度鲁特韦 Synonyms: Tivicay; |
| es-ES | Spanish (Spain) | Dolutegravir |
| it-IT | Italian (Italy) | Dolutegravir |
| tr-TR | Turkish (Turkey) | Dolutegravir |
| ru-RU | Russian (Russian Federation) | Долутегравир |
| nl-NL | Dutch (Netherlands) | dolutegravir |
| fr-FR | French (France) | Dolutégravir |
| pl-PL | Polish (Poland) | Dolutegrawir |
| el-GR | Greek (Greece) | Ντολουτεγκραβίρη Synonyms: Ντολουτεγκραβίρη |
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://